IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decheng Capital Management III (Cayman), LLC

Portfolio Profile

CIK: 0001747821 | Grand Cayman, E9

$299.6M
AUM
26
Positions
79.17%
Top 10 Conc.
99.91%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Alpine Immune Sciences, Inc.(NVLSEUR)6,708,288$76.8M25.63%
2Zentalis Pharmaceuticals Inc.(ZNTL)2,099,583$42.1M14.06%
3Aura Biosciences, Inc.(AURA)1,163,123$18.2M6.09%
4Roivant Sciences LTD(ROIV)1,459,700$17.0M5.69%
5Acelyrin Inc(nsm)1,548,317$15.7M5.26%
6Arcus Biosciences, Inc(RCUS)869,790$15.6M5.21%
710x Genomics, Inc.(TXG)359,554$14.8M4.95%
8Argenx SE(ARGX)27,429$13.5M4.50%
9Pacific Biosciences of California, Inc.(PACB)1,463,872$12.2M4.08%
10Illumnia, Inc.(ILMN)80,859$11.1M3.70%

Sector Allocation

Latest filing, equity positions only

Healthcare56.07% · $168.0M
Unclassified43.93% · $131.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare55.28%56.07%+0.79%
Unclassified44.72%43.93%-0.79%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$99.2M | 24 pos.
$60.4M | 25 pos.
$63.2M | 26 pos.
$267.2M | 26 pos.
$247.9M | 24 pos.
$318.8M | 25 pos.
Cap SizePrev %Curr %Change
Unclassified44.72%43.93%-0.79%
Micro Cap22.31%19.29%-3.02%
Mid Cap13.8%14.78%+0.98%
Small Cap11.06%13.79%+2.73%
Large Cap8.11%8.21%+0.1%
$299.6M | 26 pos.
Q1
22
Q2
22
Q3
22
Q4
22
Q1
23
Q2
23
Q3
23

Recent Activity

Quarter-over-quarter position changes

9
New
8
Closed
1
Increased
2
Decreased
14
Unchanged